Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm

By afschroeder • October 25, 2025

Lane AA, Papayannidis C, Angelucci E, McCloskey J, Schiller GJ, de la Fuente Burguera A, Montesinos P, Nagarwala Y, Herling M, Mannis G, Pemmaraju N. Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm. Leuk Lymphoma. 2025 Oct 24:1-9. doi: 10.1080/10428194.2025.2557505. Epub ahead of print. PMID: 41134616.

Tags: Adverse effects, Blastic plasmacytoid dendritic cell neoplasm, capillary leak syndrome, Hematology/Oncology, Monitoring, Publications, symptom management, tagraxofusp

Interference of Clonal Hematopoiesis in cfDNA Liquid Biopsy Testing & Identification of Actionable Alterations in Large Diverse Cohort of US Veterans

Valle LF, Scobie M, Rowe K, Pritchard CC, Montgomery B, Garraway IP, Nickols NG, Schoen MW, Kishan AU, Kelley MJ, Rettig MB, Maxwell KN. Interference[...]

Using electronic patient reported outcomes (ePROs) to improve supportive care in ambulatory oncology care: a CFIR-guided pre-implementation formative evaluation

Brauer ER, Bastani R, Cheng E, Lazaro S, Wong DJ, St John MA, Ganz PA. Using electronic patient reported outcomes (ePROs) to improve supportive care[...]

PKC inhibitors reveal PKC isoforms involved in HIV latency reversal and immunomodulation

Zaikos TD, Pham V, Chou TC, Moran JA, Turner SR, Yu BH, Hourani R, Ranjan A, Zack JA, Wender PA, Marsden MD. PKC inhibitors reveal[...]